GDPAU News & Updates



GDPAU Signs Exclusive License Agreement for an

Anti-diabetic Herbal Drug with Professor Louis Nelson


New Brunswick, NJ, February 23rd, 2009 - GDP Ayurvedic University (GDPAU), New Brunswick, NJ. Chairman and President, Professor (Dr.) Ramesh C. Pandey announced today that GDPAU has signed an exclusive worldwide license agreement for the commercialization, sales and marketing of an anti-diabetic herbal drug (currently named AD-1) with Professor Louis Nelson of Abuja, Nigeria. The history making signing ceremony was held on February 3rd, 2009 at the Sheraton Hotel in Abuja in the presence of Nigerian and International distinguished guests and dignitaries including the Honorable Minister of State for Health, Dr. Aliyu Idi Hong; Director-General of the National Institute for Pharmaceuticals Research and Development (NIPRD), Dr. Uford Inyang; and the Senate President represented by the Vice-Chairman of the Senate Committee on Health Honorable Senator Gyang Dantong.


Honorable Minister Dr. Aliyu Hong said “The occasion is an epoch and historical day in the history of Nigeria. The drug would expand the landscape of medicine in the world and encourage more researchers into herbal drugs in the Country.” The Honorable Minister further said “There is hardly a house you go to in Nigeria, that one person will not be affected by this killer disease.” He pledged the support of the Federal Government, especially those who are into herbal medicine research.


Dr. Uford Inyang, the DG of NIPRD, commended Professor Pandey for taking this bold step of signing the agreement and expressed the inability of the Federal Government to explore the enormous benefits in the herbal market. He stressed the need to focus on the herbal drugs.


Professor Nelson said “We are excited and looking forward to working with Professor Pandey and GDPAU in the further development and commercialization of AD-1 for diabetes patients worldwide.” The discovery of the anti-diabetic drug was a result of extensive research and firm commitment of Professor Nelson in the natural plant products of Nigerian biodiversity. With the financial support from Akwa Ibom State further work was carried out at NIPRD and clinical trials at University of Jos by the Nigerian scientists.


The Chairman and President of GDPAU Prof. Pandey described the drug AD-1 as the second great drug that has come out of the continent, particularly from Nigeria. The first being the herbal drug NICOSANTM for the prophylactic management of Sickle Cell Disease (SCD), which was licensed by Prof. Pandey from NIPRD in July 2002. Prof. Pandey further said, “I believe in African Natural Biodiversity and all Nigerians should be proud that they have given two herbal drugs to the world for the two important diseases.”


About Diabetes: Diabetes which afflicts over 180 million sufferers worldwide is a life threatening condition. Diabetes is a syndrome of disordered metabolism resulting in abnormally high sugar level (hyperglycemia). The World Health Organization (WHO) estimates that by the year 2030 the number of people that suffer from Diabetes will exceed 366 million.


About Prof. Nelson: Prof. Nelson, 61 holds a Ph.D. in Molecular and Computational Chemistry from the University of Ibadan and hails from Akwa Ibom State of Nigeria. He served as the Permanent Secretary in the Ministry of Science and Technology in the year 2001 and worked with the Raw Materials Research and Development Council.


About GDPAU: GDP Ayurvedic University (GDPAU) is a “not-for-profit” tax exempt 501 (c) (3) organization established in the year 2001 at New Brunswick, New Jersey with the vision to bring credibility and recognition to the Traditional Systems of Health and Medicines through research, education, training therapy and mass promotion. The mission of GDPAU is to establish a state-of-the-art center of excellence in the field of Ayurveda, Yoga and Allied Alternative System of Medicines in the USA, India and other parts of the world. GDPAU envisions a center where people, experts and researchers from “Alternative Systems of Medicines and Modern Medical System” work together for the Health Care Delivery, Health Promotion, Integral Disease Management and Adjunctive/Alternative Management of diseases, which are cost effective, reliable, easy and credible with constant support of advanced medical sciences in the respective fields. GDPAU’s website is


For Further Information Contact:

LaMonte Forthun

GDP Ayurvedic University (GDPAU)

(732) 317-8124


Prof. (Dr.) Ramesh Pandey Invited to Speak at International
Traditional Medicines Conference

New Brunswick - NJ, October 31, 2008 - GDP Ayurvedic University (GDPAU) Chairman and President, Prof. (Dr.) Ramesh C. Pandey, has been invited to be a plenary speaker at the National Institute of Pharmaceutical Education and Research’s (NIPER) “International Conference on Drug Discovery from Natural Products and Traditional Medicines” to be held at NIPER’s facilities in SAS Nagar, Punjab, India from November 16th to November 20th, 2008.

According to conference organizer, Professor K.K. Bhutani of NIPER, “The main objective of this conference is to present to the world the frontiers of Natural Product and Traditional Medicines based drug discovery programs. Drug discovery from Natural Products has reclaimed the attention of the pharmaceutical industry and is on the verge of comeback due to technological/academic inputs. This conference also intends to bring together both young and experienced scientists from all regions of the world to open up possibilities of engaging in meaningful collaborations at regional and global levels.”

Professor Pandey earned his Ph.D. from the University of Pune, National Chemical Laboratory in Pune, India. His extensive career in pharmaceutical research has spanned over 40 years with positions at the National Cancer Institute (US), Abbot Laboratories, Lyphomed and his most recent position was as the President, CEO and Chairman of the Board of Xechem International, a publically held Company located in New Brunswick, New Jersey. While at Xechem, Prof. Pandey was instrumental in the development of processes for the manufacture of Paclitaxel and second generation Paclitaxel; establishing a line of nutraceuticals that were marketed through the company’s XetaPharm subsidiary; and establishing offices in the UK, China, India and Nigeria. The Nigerian subsidiary, Xechem Pharmaceuticals Nigeria, Ltd., was established to manufacture and market NICOSAN(tm) a phytopharmaceutical for the treatment and management of Sickle Cell Disease (SCD), licensed from the National Institute of Pharmaceutical Research and Development (NIPRD) in Abuja, Nigeria. Dr. Pandey’s current projects include his mission of bringing credibility and acceptability to Traditional Systems of health and medicines to Western cultures and establishing and organizing a Multi-National Drug Discovery Team that will collaborate on a phytopharmaceutical for the treatment of Malaria and other neglected diseases.

About GDPAU - GDP Ayurvedic University (GDPAU) is a non-profit University established in New Brunswick, New Jersey in the year 2001 with the vision to bring credibility and recognition to the Traditional Systems of health and medicines through research, education, training therapy and mass promotion. The mission of GDPAU is to establish a state-of-the-art center of excellence in the field of Ayurveda, Yoga and Allied Alternative System of Medicines in the USA, India and other parts of the world. GDPAU envisions a center where people, experts and researchers from “Alternative Systems of Medicines and Modern Medical System” work together for the Health Care Delivery, Health Promotion, Integral Disease Management and Adjunctive/Alternative Management of diseases, which are cost effective, reliable, easy and credible with constant support of advanced medical sciences in the respective fields. GDPAU’s website is

About NIPER - National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’. It is an autonomous body set up under the aegis of Ministry of Chemicals and Fertilizers, Government of India. The Institute is conceived to provide leadership in pharmaceutical sciences and related areas not only within the country, but also to the countries in South East Asia, South Asia and Africa. NIPER is a member of Association of Indian Universities and Association of Commonwealth Universities. The institute is structured into ten departments catering to pharmaceutical as well as interdisciplinary scientific field of drug research viz. medicinal chemistry, natural products, pharmaceutics, pharmaceutical analysis, pharmacology and toxicology, biotechnology, pharmaceutical technology, pharmacoinformatics, pharmacy practice and pharmaceutical management. NIPER’s website is


Posted by Jag Rawat on October 08, 2008 at 7:55 am


CAN WORK ON MALARIA CURE BE ASSISTED OR BE TOTALLY POSSIBLE THROUGH AYURVEDIC APPROACH?, was one of the questions asked by Dr Jagveer Rawat to the members of post-lecture meeting. The question drew animated responses from Dr Chhikara, Principal of Kurukshetra Ayurvedic College and by Dr Ramesh C Pandey, President of GDP Ayurveda University of the US at a meeting held on the occasion of Gandhi Jayanti at Kurukshetra University, Kurukshetra on 2nd October, 2008.

Dr Chhikara quipped, "There needs a mechanism to evaluate what are the methods which are understood by all and which keeps the spirit of Ayurveda very well preserved in conducting the research of cure of malaria."

"Principles of natural sciences such as biophysics, biochemistry, immunology etc, may not be shunned but their over-reliance might kill the spirit of Ayurveda enquiry", was most repeated and rather emotional concern of the Principal of Ayurveda College.

Dr Rawat made intervention at this point and said that as far as he knows that there is no barrier at global levels to bring about regulations in place in a way by which Ayurvedic products could be evaluated for their essential Ayurvedic features with the help of proponents and luminaries of Ayurveda from India and/or abroad. For this purpose a panel could be constituted. On the other hand, there were already a sub-task Force constituted on Ayurveda under Knowledge Task Force on Pharamaceuticals by ex-Prime Minister Vajpayee in the year 2000. XContent of that Report of the sub-Task Force, remains out of the reach of the public and professionals till date.

Whatever may be the system of medicine, issues of trials of safety and those of claims made on efficacy and quality, would be regulated by the tenets of 'Food and Drug Administration', if there are claims, if any, of the cure of diseases. If the claims related to food values and nutritional impacts along with wellness enhancement, even then, usual concern relating to food safety will have to be stringently regulated.

Dr Ramesh Pandey emphasised following, "With all these, there were issues of variation in quality of 'natural bioactive compounds' emanating from plants due to variation in genomic material as well as variation in environmental conditions even of the plants of similar genotypes and varieties. Those variations are very crucial for the quality control issues of Ayurvedic medicine." This problem needs to be circumvented and there needs an institutional mechanism to answer all these questions based at upcoming facilities of research at Kurukshetra University, opined Dr Rawat.


Dr. Ramesh Pandey speaks at Kurukshetra University

Kurukshetra University (30 September, 08): Department of Biotechnology is organizing a Lecture of Dr Ramesh C Pandey, President, GDP Ayurvedic University at the occasion of Birth Anniversary of Mahatma Gandhi on 2nd October, 2008 on ‘Globalising Indian Health Systems and Tradition: Role of modern science’ at Auditorium of Kurukshetra University, Kurukshetra at 11 AM. Dr R P Bajpai, Vice-chancellor, shall be the Chief Guest. Dr Jagveer Rawat, Chief Executive of ‘Global Alliance for Right to Health or GARH’ would be Guest of Honour. 

The Lecture being organized under the aegis of Kurukshetra KURUKSHETRA: CAPITAL OF INDIAN CULTURAL COMMONWEATLH, is a step to strengthen the bid of the university to get Kurukshetra the status of Fifth Peetha as Capital of Indian Cultural Commonwealth so as to provide a special centre to ‘integrate’ members of Indian Diaspora to their roots to an ancient civilization, a geographical gap spread in Continents due to migration of about 2 Crore people of Indian origin during last 300 years.  

A special meeting chaired by the Vice-chancellor shall also be organised in presence of Dr Ramesh C Pandey to explore possibilities for designing a multi-centre CONSORTIUM on 'Globalisation of Indian Systems of Medicine for Affordale Health' and also for establishment of WORLD AYURVEDA HEALTH PARK and an Indian Cultural Commonwealth City Complex, for all those who would like to contribute to Indian medicine sector through tools of modern clinical research.  


Asian American council honors Vaz, Pandey

By George Joseph

Two Indian American were among seven people selected by the Asian American Heritage Council of New Jersey for its 2008 achievement awards.

IT entrepreneur Dr. Rajan Vaz will receive the President's Award while Dr. Ramesh Pandey, President of the Ayurvedic University, will receive the award reserved for a person from the Indian community. The awards will be presented at a gala banquet scheduled at the Meadowlands Sheraton, East Rutherford.

The finale of the Asian American heritage celebrations will be held June 1, with a parade in Bergenfield and Teaneck, Bergen County, which has a large Asian population, said Andrew Pappachen, president of the Council. Floats and dancers representing China, the Philippines, India, Korea, Taiwan, Mongolia, Vietnam, Japan, Malaysia and Bangladesh will participate in the parade.

A Gateway to Asia presentation will further showcase the principal attractions of these countries, while Asian food stalls and entertainment will be the added attraction.

Dr. Vaz, an IT veteran of 25 years, is managing director of CDC Global Services. Prior to this, he founded several successful technology firms, including Integral Information Systems whose products are now part of larger enterprises like AspenTech.

His last venture was Software Galeria, Inc., an IT services company based in New Jersey that focused on project and process outsourcing. In 2000 CDC Corporation (formerly known as chinadotcom), a leading public enterprise software and IT services firm, bought Software Galeria. In addition to IT, Dr. Vaz, a graduate of the Indian Institute of Technology, Mumbai, has contributed to the field of chemical engineering through extensive research and development activities, and has several publications to his credit.

Professor Pandey is president and CEO of the GD Pandey Ayurvedic University, based in New Jersey. He has a distinguished career in the biomedical sciences spanning over 40 years. Till last June. he was the chairman, chief executive officer and founder of Xechem, Inc., XetaPharm, Inc., Xechem (India) Pvt Ltd, and chairman of the board and CEO of Xechem International, Inc.

He has taught at several universities, and worked with many government agencies and pharmaceutical companies worldwide including the National Cancer Institute, National Chemical Laboratory, India, the University of Illinois, Rutgers University, the State University of New Jersey, and Abbott Laboratories.

For the past 10 years, he has been involved in research and development of drugs from indigenous natural sources worldwide, especially those used in traditional Chinese medicines, Ayurveda and, recently, medicinal herbs used in Nigerian folklore.

Reprinted from India Abroad, May 9, 2008


Dr. Ramesh Pandey Inducted into Cambridge Who's Who Executive, Professional and Entrepreneurial Registry

Cambridge Who's Who - New Brunswick, NJ, April 20, 2008, Dr. Ramesh C. Pandey, Chairman and President of the G. D. Pandey Ayurvedic University (GDPAU), has been recognized by Cambridge Who's Who for showing dedication, leadership and excellence in all aspects of healthcare.

Dr. Pandey has more than 40 years of professional experience in the healthcare industry. He is an expert on drug development and medicinal plant research. Dr. Pandey developed NICOSAN(TM), a drug for sickle cell anemia, while he was chairman and chief executive officer with Xechem International, Inc. Through GDPAU in collaboration with other institutions, including the University of Toronto Global Health Initiatives, he is working to develop a Traditional Medicine (TM) to treat malaria.

Dr. Pandey earned his post graduate academic degree from the University of Pune, National Chemical Laboratory, Pune in India. He stays current in his profession through research. He is working hard to bring credibility to the Indian system of Ayurvedic medicine, a science of life that treats the body as a whole, and Ayurvedic professions in the Western World. Dr. Pandey intends to set up state-of-the-art facilities in different African countries with the intention of forming an international drug discovery research group, as well as help the economy by creating more job opportunities.

As an expert on medicinal plants, he is available to speak with the media via email at [email protected].

The Cambridge Who's Who Mission
The mission of Cambridge Who's Who is to ensure that Cambridge members receive recognition, support and credibility to advance their careers. Cambridge Who's Who is also committed to delivering the highest quality networking resource for job recruitment, career enhancement and new business development. See who's making news at the
Cambridge Who's Who News Blog.

Cambridge Who's Who members have exclusive access to the biographical information of more than 200,000 successful executives, professionals and entrepreneurs at, where they use the database to share information, knowledge and services. Communication via the Cambridge Who's Who registry travels in two directions, enabling Cambridge Who's Who members to reach out when they have a business need or opportunity as well as receive information on exciting new ventures.

Link to the Press Release